Invesco Ltd. Tyme Technologies, Inc. Transaction History

Invesco Ltd.

$460 Billion
Q2 2024

Shares

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q2 2021 Aug 17, 2021	SELL	$1.14 - $1.87 $18,870 - $30,954	-16,553 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$1.34 - $3.53 $2,725 - $7,180	2,034 Added 14.01%	16,553 $29,000
Q4 2020 Feb 16, 2021	BUY	$0.87 - $1.26 $12,631 - $18,293	14,519 New	14,519 $18,000
Q1 2019 May 15, 2019	SELL	$1.76 - $3.73 $19,463 - $41,250	-11,059 Closed	0 $0
Q4 2018 Feb 14, 2019	BUY	$2.01 - $4.21 $22,228 - $46,558	11,059 New	11,059 $41,000

About TYME TECHNOLOGIES, INC.

Ticker TYME
Exchange NASDAQ
Shares Outstandng 172,207,008
Description
Tyme Technologies, Inc., a biotechnology company, develops cancer metabolism-based therapies (CMBTs) in the United States. Its lead drug product is SM-88, a CMBT that is in a Phase II/III clinical trial to treat across 15 types of cancer, including pancreatic, prostate, breast, lung, glioma, ovarian, sarcoma, and colon. The company is also devel...

More about TYME

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Invesco Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Invesco Ltd. with notifications on news.